You are visiting us from Ohio. You are located in HHS Region 5. Your Center is Great Lakes ATTC.

Search results for: medications-opioid-use-disorders-and-hepatitis-c-access-and-adherence-0

Page
...· · · · · · · · · · Medications for Opioid Use Disorders and Hepatitis C: Access and Adherence Among People Who Inj
Published: October 23, 2018
Page
...prescribed medications under a physician's supervision are much less severe than the negative effects associated with harmful use of alcohol and illicit drugs, or the misuse or abuse of prescription...
Published: December 29, 2023
Page
...that may include physical dependence, but requires other behavioral symptoms indicating loss of control over use, exacerbation of problems because of use, and continued use despite negative consequences
Published: December 29, 2023
Post
...latest treatment options for hepatitis C are antiviral medications. Most of the time, antiviral medication treatments involve daily medication for 12 weeks and depending on the specific medications being use
Published: May 10, 2018
Page
...with FQHCs to help access medications for patients with substance use disorders: FQHCs receive substantial discounts on medications; FQHCs are required to serve ≥50 percent Medicaid or Medicare eligible patients;...
Published: December 29, 2023
Post
...Many people living with hepatitis C do not know their status. Hepatitis C can be cured. Many people with hepatitis C also have co-occurring SUDs. Among new hepatitis C cases...
Published: May 17, 2022
Product or Resource
Hepatitis C virus is on the rise in rural communities of the U.S. This presentation from Judith Tsui, MD, MPH (University of Washington School of Medicine) described the syndemic of opioid use disorder (OUD) and hepatitis C (HCV). Dr. Tsui presented evidence showing the current gaps in treatment for OUD and HCV among persons who inject drugs. Based on analysis of current treatment methods and real-world patient living conditions, her presentation also described research on innovative models of care to improve treatment access and outcomes for persons with OUD and HCV. This webinar was sponsored by the Northwest ATTC and the Area Health Education Center for Western Washington (AHECWW).
Published: August 27, 2019
Event
Hepatitis C virus is on the rise in rural communities of the U.S. This presentation will describe the syndemic of opioid use disorder (OUD) and hepatitis C (HCV). Dr. Tsui will present evidence showing the current gaps in treatment for OUD and HCV among persons who inject drugs. Based on analysis of current treatment methods and real-world patient living conditions, her presentation will also describe research on innovative models of care to improve treatment access and outcomes for persons with OUD and HCV. This webinar is sponsored by the Northwest ATTC and the Area Health Education Center for Western Washington (AHECWW). Presenter Judith Tsui, MD, MPH, is an Associate Professor of Medicine, Div. of General Internal Medicine, at the University of Washington School of Medicine Download/share flyer
Published: May 22, 2019
Post
...opioid use disorders. The TIP includes an Executive Summary followed by five sections: Part 1: Introduction to Medications for Opioid Use Disorder Treatment, presents information on medications, their e
Published: February 20, 2018
ASME Article
Published: October 16, 2018
Post
...Snapshot: Introduction to Hepatitis C for Health Care Professionals, available on HealtheKnowledge. “The HCV Snapshot course helped me prepare for the ToT and gave a good overview of hepatitis C...
Published: July 23, 2019
Page
...- La adicción y el cerebro Hijacker (Spanish) - Secuestrador Refusal Skills (Spanish) - Habilidades de rechazo Teens and Opioids (Spanish) - Adolescentes y opioides Swahili Opioid Prevention M
Published: October 4, 2022
News
Join the Northwest ATTC and the Area Health Education Center for Western Washington (AHECWW) for a new webinar this June: Medications for Opioid Use Disorders and Hepatitis C: Access and...
Published: May 28, 2019
Post
...coinfected with HIV and hepatitis C have a high risk of liver-related illness and death. Viral hepatitis progresses faster and causes more liver-related health problems among people with HIV than...
Published: February 12, 2020
News
...infected with hepatitis than HIV. Hepatitis is preventable, treatable, and in the case of hepatitis C, curable. However, over 80% of people living with hepatitis are lacking prevention, testin
Published: July 12, 2019
News
...to methadone or buprenorphine, two medications that many experts consider to be the gold standards for treatment of opioid-use disorder. Advocates of offering these medications to inmates said this was...
Published: November 29, 2018
Page
...Children and Families Affected by Substance Use Disorders and Child Welfare: News You Can Use from the National Center on Substance Abuse and Child Welfare ATTC Messenger June 2016: The...
Published: August 13, 2019
Post
...evidence-based Medications for Opioid Use Disorder (MOUD) significantly reduces the risk of overdose death. These medications stabilize brain chemistry, reduce opioid effects, and relieve cravings. Reco
Published: February 5, 2024
News
Medications for Opioid Use Disorder Infographic This infographic shows the different types of medications prescribed for opioid overdose, withdrawal, and addiction. Medications for
Published: December 10, 2021
Post
...of Ukrainians who use medications to treat opioid use disorders (MOUDs) have access to take-home medications. In 2014, before the initial NIATx change team convened and offered their recommendations to.
Published: July 12, 2023
1 2 3 21
map-markermagnifiercrossmenuchevron-down